Physical activities such as walking and gardening are especially important after a stroke for younger patients, researchers found.

The new analysis included more than 92,000 TAVR patients and more than 68,000 SAVR patients.

More patients also required endovascular thrombectomy treatment than usual.

Rivaroxaban was associated with more bleeding than a placebo, researchers observed, but the overall incidence of such events was still low.

A new analysis reveals that bringing stroke treatment to the patient yields better functional outcomes.

The authors tracked data from stroke patients, and healthy controls, between the ages of 15 and 49 years old. 

The last update to these guidelines was published in 2016. 

“The commonly used target of 80% medication adherence may be inappropriate for stratifying patients with stroke, as maximal survival benefits were observed above this arbitrary threshold,” researchers said.